Heather joined Sofinnova as a Principal in 2017. She focuses on biopharmaceutical investments.
Prior to joining Sofinnova, Heather was a Senior Vice President and biotechnology sell-side analyst at Wedbush Securities, preceded by a role as associate at JMP Securities. Before joining Wall Street, Heather worked in early stage drug discovery at the Astellas Research Institute, focused on immunologic and neurologic disease areas. She was also Adjunct Professor at the Feinberg School of Medicine at Northwestern University, focused on planning lectures and mentoring students on various topics of drug discovery.
Heather received her PhD in Chemistry from Northwestern University, MS in Organic Chemistry from the Weizmann Institute of Science and her BS from Tufts University.